{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:58:06Z","timestamp":1787799486472,"version":"build-2784847793"},"reference-count":30,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>AIM: The aim of our study was primarily to analyze hospital outcomes for acute decompensated heart failure (ADHF) admissions with a comorbid diagnosis of chronic liver disease (CLD). METHODS: The NIS was used to select ADHF admissions. The population characteristics of general ADHF admissions were compared with ADHF admissions with a comorbid diagnosis of CLD. Multivariate probit logistic regression was used to analyze the association between a documented diagnosis of CLD\/alcoholic liver disease and all-cause mortality in ADHF admissions. Confounders were accounted for. Propensity scoring and nearest neighbor matching were conducted to select a matched cohort with and without CLD from ADHF admissions to further look at mortality outcomes. RESULTS: ADHF admissions with a comorbid diagnosis of CLD had a significantly higher proportion of all-cause mortality, 0.054 (0.053\u20130.057), a higher length of hospital stay, 6.95 days (6.84\u20137.06), and a higher mean of total hospital charges, USD 88,068.1, when compared to ADHF admissions without a comorbid diagnosis of CLD: all-cause mortality, 0.045 (0.044\u20130.046); length of hospital stay, 6.18 days (6.13\u20136.23); and mean total hospital charges, USD 79,946.21. A comorbid diagnosis of CLD had a significant association with all-cause mortality in ADHF admissions: OR 1.23 (1.17\u20131.29) after accounting for confounders. In the propensity-matched cohorts, the cohort with a diagnosis of CLD from the ADHF admissions had a higher proportion of all-cause mortality, 0.042 (0.036\u20130.049), when compared to the cohort without a diagnosis of chronic liver disease, 0.027 (0.022\u20130.033). CONCLUSIONS: In analyzing the mortality and healthcare utilization outcomes for ADHF admissions, the comorbid diagnosis of CLD is shown to have significantly higher all-cause mortality, higher length of hospital stay, and higher mean total charges when compared to ADHF admissions without a diagnosis of CLD. A documented diagnosis of CLD had a statistically significant association with all-cause mortality in ADHF admissions after accounting for confounding factors.<\/jats:p>","DOI":"10.3390\/medsci13010019","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T04:03:35Z","timestamp":1739419415000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes in Acute Decompensated Congestive Heart Failure Admissions with Chronic Liver Disease: A Nationwide Analysis Using the National Inpatient Sample"],"prefix":"10.3390","volume":"13","author":[{"given":"Vivek Joseph","family":"Varughese","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of South Carolina, Easley, SC 29640, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh Krishnan","family":"Nagesh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha","family":"Moliya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University of Nebraska, Omaha, NE 68001, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of South Carolina, Easley, SC 29640, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelyn","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hata","family":"Mujadzic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of South Carolina, Easley, SC 29640, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"James","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simcha","family":"Weissman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hackensack Palisades Medical Center, North Bergen, NJ 07047, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-023-01887-4","article-title":"Guideline Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction","volume":"83","author":"Patel","year":"2023","journal-title":"Drugs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10741-018-9754-4","article-title":"Updates in heart failure 30-day readmission prevention","volume":"24","author":"Goldgrab","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2023.03.430","article-title":"Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1\/3","volume":"82","author":"Patolia","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100691","DOI":"10.1016\/j.cpcardiol.2020.100691","article-title":"Physiopathology and Diagnosis of Congestive Heart Failure: Consolidated Certainties and New Perspectives","volume":"46","author":"Manno","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12098-023-04694-7","article-title":"Systemic Complications Secondary to Chronic Liver Disease","volume":"91","author":"Mannion","year":"2024","journal-title":"Indian J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e328351d003","article-title":"Complications of cirrhosis","volume":"28","author":"Rahimi","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cld.2024.03.001","article-title":"The Pathophysiology of Portal Hypertension","volume":"28","author":"Ramkissoon","year":"2024","journal-title":"Clin. Liver Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccl.2013.09.002","article-title":"The renin-angiotensin-aldosterone system and heart failure","volume":"32","author":"Sayer","year":"2014","journal-title":"Cardiol. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.jhep.2021.01.027","article-title":"Management of the major complications of cirrhosis: Beyond guidelines","volume":"75","author":"Francoz","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40119-020-00183-6","article-title":"In-Hospital Outcomes of Patients with Acute Decompensated Heart Failure and Cirrhosis: An Analysis of the National Inpatient Sample","volume":"9","author":"Khalid","year":"2020","journal-title":"Cardiol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100993","DOI":"10.1016\/j.cpcardiol.2021.100993","article-title":"Association Between Cirrhosis and 30-Day Rehospitalization After Index Hospitalization for Heart Failure","volume":"47","author":"Yazdanyar","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Toshikuni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/heartjnl-2013-305099","article-title":"Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population","volume":"100","author":"Kim","year":"2014","journal-title":"Heart"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","article-title":"Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease","volume":"20","author":"Ballestri","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semnephrol.2011.09.005","article-title":"Use of diuretics in heart failure and cirrhosis","volume":"31","author":"Schrier","year":"2011","journal-title":"Semin. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: Clinical pharmacology","volume":"31","author":"Brater","year":"2011","journal-title":"Semin. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep4.1510","article-title":"Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Valbusa, F., Bonapace, S., Agnoletti, D., Scala, L., Grillo, C., Arduini, P., Turcato, E., Mantovani, A., Zoppini, G., and Arcaro, G. (2017). Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173398"},{"key":"ref_23","first-page":"244","article-title":"Liver complications in patients with congestive heart failure","volume":"9","author":"Giallourakis","year":"2013","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/apt.17631","article-title":"Effects of social determinants of health on mortality and incident liver-related events and cardiovascular disease in steatotic liver disease","volume":"58","author":"Chen","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e036265","DOI":"10.1161\/JAHA.124.036265","article-title":"Neighborhood Socioeconomic Disadvantage and 30-Day Outcomes for Common Cardiovascular Conditions","volume":"13","author":"Lusk","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e009362","DOI":"10.1161\/CIRCHEARTFAILURE.121.009362","article-title":"Disparities in Hospital Length of Stay Across Race and Ethnicity Among Patients with Heart Failure","volume":"15","author":"Zheng","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_27","first-page":"1169","article-title":"The Impact of Health Care Disparities on Patients With Heart Failure","volume":"28","author":"Morris","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Riazi, K., Swain, M.G., Congly, S.E., Kaplan, G.G., and Shaheen, A.A. (2022). Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients, 14.","DOI":"10.3390\/nu14214556"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HCO.0000000000000855","article-title":"Racial and ethnic disparities in heart failure: Current state and future directions","volume":"36","author":"Lewsey","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14740\/gr1439","article-title":"Ethnic Minorities and Low Socioeconomic Status Patients with Chronic Liver Disease Are at Greatest Risk of Being Uninsured","volume":"14","author":"Ohikere","year":"2021","journal-title":"Gastroenterol. Res."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:32:27Z","timestamp":1760027547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medsci13010019"],"URL":"https:\/\/doi.org\/10.3390\/medsci13010019","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}